Oral exposure of pigs to the mycotoxin deoxynivalenol does not modulate the hepatic albumin synthesis during a LPS-induced acute-phase reaction

Abstract

The sensitivity of pigs to deoxynivalenol (DON) might be influenced by systemic inflammation (SI) which impacts liver. Besides following acute-phase proteins, our aim was to investigate both the hepatic fractional albumin (ALB) synthesis rate (FSR) and the ALB concentration as indicators of ALB metabolism in presence and absence of SI induced by LPS via pre- or post-hepatic venous route. Each infusion group was pre-conditioned either with a control diet (CON, 0.12 mg DON/kg diet) or with a DON-contaminated diet (DON, 4.59 mg DON/kg diet) for 4 wk. A depression of ALB FSR was observed 195 min after LPS challenge, independent of feeding group or LPS application route, which was not paralleled by a down-regulated ALB mRNA expression but by a reduced availability of free cysteine. The drop in ALB FSR only partly explained the plasma ALB concentrations which were more depressed in the DON-pre-exposed groups, suggesting that ALB levels are influenced by further mechanisms. The abundances of haptoglobin, C-reactive protein, serum amyloid A, pig major acute-phase protein, fibrinogen and LPS-binding protein mRNA were up-regulated upon LPS stimulation but not accompanied by increases in the plasma concentrations of these proteins, pointing at an imbalance between synthesis and consumption.

Keywords

Pig albumin synthesis deoxynivalenol acute-phase reaction haptoglobin C-reactive protein serum amyloid A pig major acute-phase protein fibrinogen LPS-binding protein

Introduction

LPS are constituents of cell envelopes of most Gram-negative bacteria^1–3 and belong to PAMP molecules.⁴ As such, they are recognized by highly conserved surface receptors, most importantly by TLR4 and CD14, and particularly when LPS is bound to LPS-binding proteins (LBP).⁵,⁶ TLR4/CD14 and co-receptor molecules are present on various cell types, notably on monocytes and macrophages, but also on hepatocytes.⁷ Following binding, a signal transduction cascade is initiated, finally resulting in the expression of a number of inflammatory cytokines, such as TNF-α, driving the acute-phase response (APR).²,^8–11 Ultimately, this results in a modulation of tissue protein turnover, particularly in the liver and skeletal muscle.¹² Among others, the APR includes an up-regulation of those hepatic export proteins necessary for the innate immune response and that are termed positive acute-phase proteins (APP), for example serum amyloid A (SAA), pig major acute-phase protein (MAP), C-reactive protein (CRP), haptoglobin (HP) and others. In addition, other export proteins, i.e. the negative APP (e.g. albumin (ALB) and others) are down-regulated¹¹,¹³,¹⁴ in order to support the synthesis of positive APP by providing free Aa. In skeletal muscle, pro-inflammatory cytokines stimulate protein degradation which additionally provides Aa for the hepatic synthesis of positive APP.¹⁵

Xenobiotics differ markedly in their biological effects and are always present in feed and food at varying levels. Deoxynivalenol (DON) is a mycotoxin formed by several species of the genus Fusarium primarily prior to harvesting the crops.^16–18 If critical levels of DON in the diets for farm animals are exceeded, adverse effects cannot be excluded.¹⁹ In particular pigs have a quite sensitive response, with a reduction in feed intake. Furthermore, DON is frequently discussed regarding inhibition of protein synthesis at the molecular level,^16–18 although experimental findings with pigs are inconsistent.^20–23 This inconsistency might be because sensitivity to xenobiotics such as DON might be modulated by inflammation.^24–26 If inflammation is initiated by LPS, the route of entry into the organism might further modulate the sensitivity to DON because the liver plays a crucial role both in clearance of LPS and in triggering the APR as an immanent part of a systemic inflammation (SI). Although ALB appears to be a rather weak negative APP in pigs,¹³ its role in the APR should not be neglected as it accounts for the vast majority of hepatic exported proteins detectable in systemic blood. The contribution of porcine ALB synthesis to total hepatic protein synthesis was estimated to vary between 11 and 22%.²¹ Therefore, even small changes in ALB turnover, triggered by the putative interaction between DON and LPS in the liver, might have consequences for the APR status. Furthermore, in routine diagnostics usually only the changes in ALB concentration are used for evaluation of ALB turnover and extent of APR. However, the ALB concentration in the systemic circulation is the net result of hepatic synthesis, transcapillary ALB transfer and ALB degradation.²⁷,²⁸ Therefore, a given blood ALB concentration is not indicative of ALB turnover. As these processes might have different implications for metabolism under the conditions of an APR and possibly for the resolution of the inflammation, the quantification of individual processes of ALB metabolism could be helpful for interpreting the observed outcomes.

Therefore, the aim of the present study was to examine both the fractional ALB synthesis rate and the ALB concentration as indicators of ALB metabolism in the presence and absence of SI. The latter was induced by infusion of LPS either via the pre-hepatic or post-hepatic route to elucidate the specific role of the liver in mediating a generalized SI. Moreover, to investigate the interactions between DON and LPS in more detail, each infusion group was conditioned either with a control diet containing a low background DON contamination (CON, 0.12 mg DON/kg diet) or with a DON-contaminated diet (DON, 4.59 mg DON/kg diet). To further characterize liver metabolism and APR under the described experimental conditions, indicators of liver protein turnover as well as hepatic mRNA- and protein abundances of further APP were determined.

Material and methods

Experimental design and procedures

The current investigations were part of a comprehensive experiment for studying the effects of DON in LPS-challenged pigs. Details of the experiment, including diet composition, housing conditions and surgical procedures were reported earlier.²⁹,³⁰

Experiments and procedures were in accordance with the European Community regulations concerning the protection of experimental animals and the guidelines of the German Animal Welfare Act, and were approved by the ethical committee advising the Lower Saxony State Office for Consumer Protection and Food Safety (file number 33.4-42502-04-13/1274).

Briefly, a total of 41 barrows (German Landrace) with an initial mean body mass (BM) of 25.8 ± 3.7 kg were fed either a control diet (CON, 0.12 mg DON/kg diet) or a diet mainly contaminated with DON (DON, 4.59 mg DON/kg diet)for 4 wk starting at d 0.

At d 27 of the experiment, all animals were surgically equipped with indwelling systemic (jugular = post-hepatic) and portal (pre-hepatic) venous catheters. At d 29, pigs of the two feeding groups were randomly assigned to three infusion groups each with LPS (7.5 µg/kg BM dissolved in 0.9% NaCl, Escherichia coli O111:B4, product number L2630, Sigma-Aldrich, Taufenkirchen, Germany) either in jugular or portal vein (LPSju or LPSpo, respectively) or with physiological saline (0.9% NaCl) solution (CONju and CONpo, respectively). The resulting six treatments were abbreviated as shown in Figure 1.

Figure 1.

Experimental design: Pigs were fed either a control diet (CON) or a diet contaminated with mainly deoxynivalenol (DON) for 4 wk. At d 29 of experiment pigs of the two feeding groups were randomly assigned to three treatment groups each and were infused for 60 min with either a LPS solution, in jugular or portal vessels (LPSju or LPSpo, respectively), or with a saline solution (CONju and CONpo, respectively). Downstream arrows indicate time points of blood (APP, acute-phase proteins; ALB-[²H₅]-Phe, samples for determination of Phe enrichment) and tissue sampling, while upstream arrow relates to the isotope tracer infusion – for further details see text.

Pigs were fed with 700 g feed per animal according to their feeding group at 15 min prior to start of the infusions. At -30 and 180 min relative to the start of the infusion blood samples for the analyses of APP were collected from the external jugular vein.

For quantifying the newly synthesized ALB and total liver protein, the flooding dose technique was applied as originally described for humans and experimental rodents³¹,³² and later adjusted for pigs.³³

All pigs were injected with 5 ml/kg BM of a deuterated phenylalanine (Phe) solution (150 mMol/l, 29 molar percent excess (MPE) of l-[²H₅] Phe; 125 mg total Phe/kg BM) prepared from l-Phe and l-[²H₅]-Phe (Cambridge Isotope Laboratories Inc, Andover, MA, USA, 98% isotopic enrichment) at 105 min relative to the start of LPS/saline infusion into the internal jugular vein. Blood samples were collected at 30, 45, 60 and 90 min relative to Phe injection from the external jugular vein using Li-Heparin Monovette® (Sarstedt AG & Co., Germany). Blood samples were centrifuged (1915 g for 15 min at 15°C) for separating plasma and stored at –80°C until further sample preparation and analyses.

Non-perfused liver tissue samples (Lobus hepatis dexter medialis) were obtained after slaughtering the pigs by electrical stunning and exsanguination at 195 min, immediately snap frozen in liquid nitrogen and subsequently stored for further processing at –80°C.

Synthesis of albumin and hepatic proteins

Determination of protein synthesis rates of ALB and total liver protein required the separation of free Phe from protein-bound Phe and involved an initial precipitation of plasma and tissue proteins using trichloroacetic acid and perchloric acid, respectively, as described in detail elsewhere.²¹,²³ Supernatants were used for further purification and analysis of tissue free Aa (see section Hepatic free and protein-bound amino acid composition), plasma and tissue free [²H₅]-Phe, representing the protein synthesis precursor pools, while protein-containing pellets were further processed as described in detail earlier for determination of the protein-bound Aa (see section Hepatic free and protein-bound amino acid composition) and [²H₅]-Phe.²²,²³ In the case of liver samples, this procedure involved the sequential isolation of fractions for determination of total protein, RNA and DNA. These fractions were quantified using photometric methods as described in detail elsewhere.²⁰

Acute-phase proteins

Haptoglobin was measured by ELISA as described earlier.³⁴ For Pig-MAP (pig major acute-phase protein, also known as ITIH4), a commercially available ELISA (ACUVET Biotech, Zaragoza, Spain) that was standardized to the European reference serum for APP (EU Concerted action QLK5-CT-1999-0153) was used. Serum amyloid A (SAA) was also measured by ELISA (Phase™, SAA Assay Multispecies Cat. No. TP-802, Tridelta, Kildare, Ireland) using the control material provided by this company (Cat. No. TP802-Con). For CRP, the Turbovet CRP pig assay, a particle enhanced turbidimetric immunoassay was used (ACUVET Biotech).

Expression of acute-phase protein genes

Frozen liver tissue was homogenized in liquid nitrogen using a 6770 Freezer/Mill® (SPEX SamplePrep LLC, New Jersey, USA) and from the resulting powder total RNA was isolated applying the NucleoSpin® RNA kit (Macherey-Nagel GmbH & Co. KG, Düren, Germany) according to the manufacturer’s protocol. Concentration and quality of the purified RNA were determined with a NanoDrop® ND-1000 (NanoDrop Technologies Inc., Wilmington, DE, USA) and RNA integrity was verified using agarose gel electrophoresis including 0.06% sodium hypochlorite (adapted from³⁵). One microgram of RNA was transcribed into cDNA with the qScript™ cDNA Synthesis Kit (Quanta Biosciences™, Inc., Gaithersburg, MD, USA) according to the manufacturer’s protocol. Gene-specific primer pairs (Table 1) were generated using Primer-BLAST³⁶ and obtained from Eurofins Genomics GmbH (Ebersberg, Germany). The generation of a single PCR product was evaluated by melting curve analysis, the product length was verified on 2% agarose gel electrophoresis and the PCR products were confirmed by sequencing. Primer efficiencies were calculated using a five-point dilution series of a cDNA sample mixture of the experiment. qPCR runs were conducted in duplicate 15 µl reactions on a CFX96™ Real-Time PCR System (Bio-Rad Laboratories, Hercules, CA, USA) using iTaq™ Universal SYBR® Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA). The primers were added in the concentrations listed in Table 1 and the cDNA equivalent of 22.5 ng RNA was included. After an initial denaturation step of 30 s at 95°C, 40 cycles of 5 s denaturation at 95°C and 30 s of annealing and elongation at 60°C followed. The presence of a single PCR product was confirmed in each well with a melting curve from 60°C to 95°C in 0.5°C increments for 5 s each and every run was controlled by a no-template control in triplicate. Cq-Values of target and reference genes were obtained using CFX Manager™ Software 3.1 (Bio-Rad Laboratories, Hercules, CA, USA) and the evaluation was done with qbase+ (Version 3.1, Biogazelle, Zwijnaarde, Belgium). The optimal reference genes GAPDH, HPRT and TBP were identified with a geNorm analysis out of nine reference targets³⁷ and exhibited a mean reference target stability M value of 0.36. The normalized, relative expression levels were calculated using the geometric mean of the above-mentioned reference genes as normalization factor, relating the data to the geometric mean of all CON_CONjug_CONpo animals (ΔΔCq), and taking in consideration the primer pair-specific amplification efficiencies.³⁸

Table 1.

Characteristics of gene-specific primers used for qRTPCR.

Gene	NCBI GenBank accession no.	Sequences (forward/reverse)(5′–3′)	Amplicon size (bp)	Concentration for/rev (nM)	Efficiency (%)
Reference genes
GAPDH^§	DQ845173.1	F- ACACTCACTCTTCTACCTTTG R- CAAATTCATTGTCGTACCAG	90	500/500	103.0
HPRT1	NM_001032376.2	F- GCAGCCCCAGCGTCGTGATTA R- TCGAGCAAGCCGTTCAGTCCT	143	500/500	100.5
TBP^§	DQ845178.1	F- AACAGTTCAGTAGTTATGAGCCAGA R- AGATGTTCTCAAACGCTTCG	153	500/500	99.0
Target genes
ALB	NM_001005208.1	F- ATGCTATGCCACAGTGTTTGA R- TTGCGACCTCCACAAGAGTT	179	333/333	96.1
CRP	NM_213844.2	F- CCTAGATGACTGCCTGTGTTT R- ACAATAAATGGGGTGGATGTGC	81	333/333	101.7
FGG	NM_001244524.1	F- ACGACACAACTGGGAAAGATTG R- TGAAATCCTCACTGCCGTCC	177	250/250	97.7
HP	NM_214000.2	F- TGGTTCGCTATCACTGCCAA R- CCGCACACTGCTTCACATTC	133	333/333	95.9
ITIH4 (MAP)	NM_001001537.1	F- CGGCCCACAAGAATGACATC R- CTGGGTAGGTCACACCATCG	198	100/250	95.8
LBP	NM_001128435.1	F- GGCTTCCTTGCTCCTGTCAT R- GTTGGTGGTCAGTCGGATGT	177	333/333	101.2
SAA3	NM_001044552.1	F- TCCTCAAGGAAGCTGGTCAAG R- CTGGCATCGCTGATCACTTTAG	169	250/250	95.1

GAPDH: glyceraldehyde-3-phosphate dehydrogenase; HPRT1: hypoxanthine phosphoribosyltransferase 1; TBP: TATA box binding protein; ALB: albumin; CRP: C-reactive protein, pentraxin-related; FGG: fibrinogen gamma chain; HP: haptoglobin; ITIH4: inter-alpha-trypsin inhibitor heavy chain 4 = major acute-phase protein (MAP); LBP: LPS-binding protein; SAA3: serum amyloid A-3 protein. ^§Primers for GAPDH and TBP are from,⁸⁰ all others from this study.

Hepatic free and protein-bound amino acid composition

The combined supernatants of protein precipitation were neutralized with 2 M K₂CO₃ in the ratio 14:1 and diluted by factor 2 with ultrapure water.

About 5 mg of dried protein pellet was hydrolyzed with 2 ml 6 N HCl with ascorbic acid as antioxidant under N₂ atmosphere at 110°C for 20 h. After evaporation to dryness under nitrogen stream at 60°C, hydrolyzed samples were re-dissolved in 0.1 N HCl and diluted by factor 50 with ultrapure water.

Aa concentrations were determined by HPLC using pre-column derivatization and fluorescence detection (1200 series, Agilent Technologies, Waldbronn, Germany). Briefly, Aa were derivatized with ortho-phthaldialdehyde/3-mercaptopropionic acid (OPA) and 9-fluorenylmethoxycarbonyl chloride (FMOC). The separation was carried out on a Hyperclone 5 µm reversed-phase C18 column (250 × 4 mm i.d.) protected by a 4 × 3 mm pre-column (both Phenomenex, Aschaffenburg, Germany) at 40°C. Fluorescence of Aa derivatives was monitored at excitation and emission wavelengths of 340 and 450 nm (OPA) or 266 nm and 305 nm (FMOC), respectively. Aa standard solution from Sigma-Aldrich (A9906, Munich, Germany) was used, and additional standards for Asn, Gln, Trp, Met sulfoxide and Met sulfone were prepared. Because of acid hydrolysis, Asn and Gln were converted to Asp and Glu and analysed as such. Cys and Trp could be not analysed. Met was calculated as the sum of Met, Met sulfoxide and Met sulfone.

Calculations and statistics

The fractional protein synthesis rate (FSR) of total liver proteins, expressed as percent per d, was calculated as follows:³²

FSR = \frac{{MPE}_{b}}{{MPE}_{f}} \cdot \frac{1}{t} \cdot 100

(1)

where MPE_b and MPE_f represents the molar percent excess of [²H₅]-Phe in protein and in free precursor pool, and t is time, expressed in ds. For the precursor pool either the enrichment of the plasma free or tissue free Phe was used for calculations to determine a minimum and maximum FSR (FSR_minimum and FSR_maximum), respectively, to account for the uncertainty of the real protein synthesis precursor pool.

Absolute total liver protein synthesis rate (ASR) was calculated by multiplying the absolute organ protein mass (organ mass multiplied by protein content) with the respective FSR_maximum divided by 100.

The analytically determined hepatic concentrations of protein, RNA, DNA were used to derive further parameters of protein metabolism such as RNA to protein ratio as indicator for protein synthesis capacity, protein to DNA ratio for cell size, ASR to RNA ratio, and ASR to DNA ratio for translational efficiency and DNA activity, respectively.

FSR of ALB was calculated according to Ballmer et al.³⁹ as the ratio between the time-related linear increase in MPE of ALB and the corresponding area under the MPE–time curve of the precursor pool (plasma free l-Phe) multiplied by 100. The ASR of ALB was estimated by multiplying the FSR of ALB with the intravascular ALB mass. The latter was determined by multiplying the measured plasma ALB concentration with the estimated plasma volume (Plasma volume = 1.06 + 0.037 · BM (kg)).⁴⁰ Regressions of l-[²H₅]-Phe MPE in ALB on time were extrapolated to a zero-MPE to enable estimation of the time of first appearance of the label in the systemic circulation, which is equivalent to the hepatic ALB secretion time.

Data were evaluated by ANOVA with treatment group as fixed factor. Significant treatment effects (p < 0.05) were further assessed by the least significant difference test. The differences in APP concentrations between the time span from −30 min to 180 min relative to starting the infusions were not normally distributed and evaluated by the non-parametric Mann–Whitney U-test. Data were further analysed using correlation and regression analysis. All statistics were performed using the software package STATISTICA 13.0.⁴¹

Results

Acute-phase proteins

The concentrations of CRP, MAP, SAA, HP and ALB were not different (P > 0.05) between the feeding groups 30 min prior to start of infusions and amounted to 0.07 (0.03–0.18), 2.63 (1.16–3.97), 0.09 (0.01–0.24), 1.68 (0.83–2.79), and 33.9 (27.4–40.6) mg/ml on average (min–max), respectively. The corresponding APP concentrations 3 h after start of infusion were also not affected by treatments with exception of ALB concentrations. The mean CRP, MAP, SAA and HP levels were found to be 0.08 (0.03–0.18), 3.08 (1.56–5.39), 0.12 (0.01–0.37) and 1.98 (1.09–3.02) mg/ml, respectively. ALB concentrations were decreased in DON-fed groups infused with LPS irrespective of infusion site (Figure 2a) compared with the CON group infused with physiological saline while insignificant intermediate ALB concentrations were found for the other treatments.

Figure 2.

Plasma ALB content [A], fractional synthesis rate (FSR) of ALB [B], linear regression of ALB secretion time vs. ALB FSR [C], minimum (black bars) and maximum (white bars) liver protein FSR [D], linear regression of absolute synthesis rate (ASR) of ALB vs. liver protein ASR [E], and linear regression of hepatic protein FSR vs. liver histology index (data from Renner et al.⁴²) [F] of pigs fed either a control diet (CON) or a diet contaminated mainly with deoxynivalenol (DON) and following either jugular or portal LPS stimulation (LPSju or LPSpo, respectively; CONju and CONpo indicate placebo NaCl infusion). Columns indicate least square means (LSMEANS) and whiskers standard error of means. ab, LSMEANS with no common superscripts are significantly different (p < 0.05).

The relative changes in APP concentrations at 3 h, expressed as percentage of the initial levels at −30 min, were influenced by treatments for all measured APP, except for CRP (Figure 3). MAP levels decreased more pronouncedly after LPS infusion in DON-fed groups compared with both saline groups. Moreover, LPS infusion via the jugular vein resulted in a significantly steeper decrease when compared with portal vein LPS exposure. Such LPS effects on time-related MAP change were not observed in CON-fed groups. Similar to MAP alterations, the SAA concentrations decreased more pronouncedly in LPS-treated pigs fed DON-contaminated feed, although LPS infusion site did not induce an additional difference. A significant decrease in HP concentration was noticed in CON-fed groups exposed to LPS independently of infusion site when compared with the unexposed CON group. In DON-fed groups the LPS infusion via the jugular vein caused a significantly steeper decrease in HP concentration compared with the placebo DON-fed group, while portal LPS exposure caused a decrease in HP content comparable to both CON and DON-fed groups not exposed to LPS. Both DON-fed groups responded to LPS infusions with a decrease of ALB concentrations by approximately 20% compared with CON group not challenged with LPS. A similar decrease was noticed for the CON-fed group exposed to LPS via the jugular vein when compared with the non-LPS-infused CON and DON-fed groups.

Figure 3.

Change of acute-phase protein concentrations over time (-30 min to 180 min relative to infusion start) in heparinized plasma from Vena jugularis externa of pigs fed either a control diet (CON) or a diet mainly contaminated with deoxynivalenol (DON)and following either jugular or portal LPS stimulation (LPSju or LPSpo, respectively; CONju and CONpo indicate placebo NaCl infusion). Boxes indicate the 25th and 75th percentile, dashes the medians and whiskers the minimum and maximum values. Different lower-case letters indicate significant differences between treatment groups for individual acute phase proteins (Mann–Whitney U-test, p < 0.05).

ALB synthesis and liver protein metabolism

The MPE of free l-[²H₅]-Phe in blood was used as indicator for the precursor pool for ALB synthesis and decreased linearly over time (average r² = 0.92; 0.69–1.0) while MPE of l-[²H₅]-Phe bound in ALB increased linearly (average r² = 0.99; 0.94–1.0). The corresponding slopes of the linear regressions depended mainly on LPS treatment and suggested a less pronounced MPE decrease in the precursor pool and a lower increase in ALB for groups treated with LPS (Figure 4).

Figure 4.

Time-dependent changes in the enrichment of Phe, expressed as molar percent excess (MPE) of l-[²H₅]-Phe, in the precursor pool (free Phe in blood, squares) and bound in albumin (circles) exemplarily for 2 CON-fed pigs receiving either physiological saline (■, ●) or LPS treatment (□, ○) via the internal jugular vein. Regressions of MPE in albumin on time were extrapolated to a zero-MPE to enable estimation of the time of first appearance of the label in the systemic circulation which is equivalent to the hepatic albumin secretion time.

Feeding of DON-contaminated diets did not adversely affect ALB synthesis when infused with saline (Figure 2b), whereas LPS treatment induced a significant reduction in ALB synthesis rate irrespective of feeding regimen or LPS infusion site. Compared with placebo-infused CON- and DON-fed groups, the mean absolute decrease amounted to 16% units, which is equivalent to a relative reduction by 40%. The animal-individual ALB secretion time varied between approximately 11 and 28 min and was not influenced by treatments (Table 2, Figure 2c). ALB secretion time increased linearly with ALB FSR (Figure 2c). The slope of this regression suggested a mean increase in secretion time by 0.2 min for each increase in ALB synthesis rate by 1%.

Table 2.

Absolute ALB and total liver protein synthesis rates (ASR) and further liver protein metabolism traits (Least square means, LSmeans).

	Group						P Values	PSEM
	CON_CONju/CONpo	CON_CONju/LPSpo	CON_LPSju/CONpo	DON_CONju/CONpo	DON_CONju/LPSpo	DON_LPSju/CONpo	P Values	PSEM
n	8	7	7	7	6	6
ALB
ASR (mg/kg BM/d)	878.5^b	467.9^a	482.8^a	838.7^b	497.7^a	433.0^a	< 0.001	39.3
ASR (% of total liver ASR)	43.0^b	28.1^a	33.0^a	42.6^b	30.9^a	27.6^a	0.008	1.7
Secretion time (min)	22.2	19.1	20.6	22.5	19.9	20.4	0.472	0.6
Liver
Protein (µg/mg)	167.6	189.3	181.0	171.5	186.7	187.3	0.141	3.0
RNA (µg/mg)	5.6	5.5	5.2	6.3	6.1	6.6	0.540	0.2
DNA (µg/mg)	2.0	1.9	2.0	1.9	2.2	2.1	0.461	0.0
RNA:protein (mg/g)	34.3	29.2	29.2	38.0	33.3	35.4	0.556	1.6
RNA:DNA (mg/mg)	2.8	3.0	2.7	3.3	2.8	3.1	0.692	0.1
Protein:DNA (mg/mg)	85.5	101.6	91.7	89.6	87.4	89.9	0.398	2.3
ASR (g/kg BM/d)	2.0^c	1.7^ab	1.5^a	2.0^bc	1.6^ab	1.6^a	0.026	0.1
ASR (mg/mg RNA)	18.6	12.5	12.9	16.1	11.2	9.8	0.056	0.9
ASR (mg/mg DNA)	49.0^b	33.7^a	31.4^a	49.3^b	29.6^a	28.1^a	< 0.001	1.9

The ASR of ALB, expressed in mg/kg BM and d, revealed similar significance relationships as described for fractional ALB synthesis rate. Thus, the LPS-infused groups synthesized on average approximately 388 mg ALB less than the groups not exposed to LPS (–45%; Table 2).

The FSR of total liver proteins was influenced by treatments in a similar fashion as described for ALB synthesis (Figure 2d). Thus, a mean relative decrease in FSR of 39% was noticed for LPS-infused groups compared with the placebo-infused groups irrespective of whether intracellular or plasma free Aa were considered as precursor pools (FSR_minimum and FSR_maximum, respectively). In general, FSR_minimum was systematically lower compared with FSR_maximum whereby absolute differences amounted to 6% and 3% for non-challenged and LPS-infused groups, respectively (data not shown).

As FSR of total liver proteins followed similar significance patterns as described for ALB FSR, the proportion of the ALB ASR of total liver ASR was influenced by treatments in a similar manner. Here, the mean proportion of ALB ASR was 13% (30% relative change) higher in saline-exposed groups compared with all four LPS-infused groups (Table 2). A general view of this parameter revealed a variation of the proportion of the ALB ASR of hepatic ASR between approximately 28 and 43%. The slope of the corresponding linear regression supports this magnitude and suggested a mean proportion of approximately 40% (Figure 2e).

Hepatic concentrations of total protein, DNA and RNA were not significantly influenced by treatments (Table 2). Also, protein synthesis capacity, expressed as the ratio between total RNA and protein, protein to DNA ratio as indicator for cell size and RNA to DNA ratio were not affected by treatments. ASR of total liver proteins reached approximately 2 g/kg BM/d in both groups not challenged with LPS, while lower rates (p < 0.05) were noticed in groups infused with LPS via the jugular vein independently of diet type. LPS application via the portal vein resulted in a less pronounced depression in ASR (Table 2). A trend for a decreased translational efficiency, i.e. the ASR to RNA ratio, was noticed for the LPS-infused groups. In contrast, the DNA activity, i.e. the ratio between ASR and DNA, revealed a clear picture as all LPS-infused groups synthesized significantly less total hepatic protein when compared with the unchallenged groups (–38% on average).

Renner et al.⁴² could already demonstrate a significant increase in histopathological alterations in the same pigs as used in the present investigations. The severity of these lesions was evaluated together with the FSR of total hepatic proteins through linear regression. Each increase in severity of histopathological lesions by one score-point was associated to a mean decrease of FSR of total hepatic proteins by 2.5% as suggested by the corresponding linear regression (Figure 2f).

Hepatic free and protein-bound amino acid composition

The concentrations of cysteine and alpha-aminoadipic acid were lower in LPS-infused groups in the supernatants containing the free Aa with a similar trend for Asn (Figure 5). The remaining Aa and metabolites were not influenced by treatments (Supplemental Table 1). The concentration of cysteine in the hepatic free Aa precursor pool was linearly related to the FSR of ALB and hepatic total protein (Figure 6).

Figure 5.

Aa concentrations in supernatants of liver homogenates (free amino acids, µMol/g) of pigs fed either a control diet (CON) or a diet mainly contaminated with deoxynivalenol (DON) and following either jugular or portal LPS stimulation (LPSju or LPSpo, respectively; CONju and CONpo indicate placebo NaCl infusion). Columns represent least square means (LSMEANS +SE). Different lower-case letters close to the upper whiskers indicate significant differences between treatment groups for individual amino acids (P < 0.05). Black: Cys (P = 0.014), red: alpha-aminoadipic acid (P = 0.046), blue: Asn (P = 0.054).

Figure 6.

Linear regression of cystine concentration in the hepatic free Aa precursor pool on fractional albumin synthesis rate (FSR) [A] and on FSR of total liver proteins [B].

The concentrations of His, Asp, Ala, Val and Leu in the protein hydrolysate tended to be increased in LPS-exposed pigs compared with the non-exposed groups (P < 0.1, Figure 7). The concentrations of the other proteinogenic Aa remained unaffected by any of the treatments (Supplemental Table 2).

Figure 7.

Aa concentrations in hydrolysates of total liver proteins (µMol/g) of pigs fed either a control diet (CON) or a diet mainly contaminated with deoxynivalenol (DON) and following either jugular or portal LPS stimulation (LPSju or LPSpo, respectively; CONju and CONpo indicate placebo NaCl infusion). Columns indicate least square means (LSMEANS+SE) and whiskers standard errors of LSMEANS. White: Asp (P = 0.098), red: His (P = 0.081), grey: Ala (P = 0.090), green: Val (P = 0.083), blue: Leu (P = 0.090).

Hepatic gene expression of APP

The mRNA abundance of the negative APP ALB was not influenced by any of the treatments (Table 3). In contrast, the mRNA expression of all measured positive APP was stimulated by LPS application independent of the infusion site, albeit the order of magnitude differed substantially (Table 3). The SAA3 mRNA abundance was much more induced compared with fibrinogen (Fib), HP, MAP, CRP, and LBP mRNA. Interestingly, the mRNA abundance of only SAA3 was significantly decreased in DON-fed pigs not challenged with LPS compared with their CON-fed counterparts (Table 3), while such effects were not observed for the other APP.

Table 3.

Relative mRNA abundance of hepatic acute-phase proteins determined at 195 min after LPS infusion start (Least square means, LSmeans)

	Group						p Values	PSEM
Gene name	CON_CONju/CONpo	CON_CONju/LPSpo	CON_LPSju/CONpo	DON_CONju/CONpo	DON_CONju/LPSpo	DON_LPSju/CONpo	p Values	PSEM
n	8	6	8	7	7	6
ALB	1.0	1.1	1.2	1.2	0.9	1.3	0.126	1.1
CRP	1.0^a	2.1^b	1.7^b	1.3^ab	2.1^b	2.1^b	0.015	1.2
FGG	1.0^a	2.7^b	2.3^b	1.2^a	2.5^b	2.6^b	< 0.001	1.1
HP	1.0^a	1.5^b	1.5^b	1.0^a	1.7^b	1.9^b	< 0.001	1.1
ITIH4 (MAP)	1.0^a	1.8^b	1.8^b	0.8^a	2.1^b	2.3^b	<0.001	1.1
LBP	1.0^a	1.7^b	1.7^b	0.9^a	1.6^b	1.7^b	< 0.001	1.2
SAA3	1.0^b	123.2^c	119.1^c	0.5^a	129.9^c	152.5^c	<0.001	1.2

CON_CONju/CONpo, uncontaminated control diet (CON), placebo NaCl infusion (CONju/CONpo), CON_CONju/LPSpo, CON, LPS infusion via portal vein (LPSpo), CON_LPSju/CONpo, CON, LPS infusion via jugular vein (LPSju), DON_CONju/CONpo, deoxynivalenol contaminated diet (DON), CONju/CONpo, DON_CONju/LPSpo, DON, LPSpo, DON_LPSju/CONpo, DON, LPSju. ALB: albumin; CRP: C-reactive protein, pentraxin-related; FGG: fibrinogen gamma chain; HP: haptoglobin; ITIH4: inter-α-trypsin inhibitor heavy chain 4 = major acute-phase protein (MAP); LBP: LPS-binding protein; SAA3: serum amyloid A-3 protein. ^a–cLSmeans with no common superscripts are significantly different (P < 0.05). PSEM, pooled standard error of LS means.

Discussion

The liver plays a central role in metabolism and supports extra-hepatic tissues by providing nutrients and energy for metabolic purposes.⁴³ On the other hand, it is also an important secondary immunological organ and forms a second line of defence against Ags, xenobiotics like DON, and other substances which overcome the gastro-enteral mucosal barrier at the first pass. Second-pass delivery of these substances to the liver might result from peripheral sources. The defence mechanisms of the liver are directed to cope with those substances in a way that mediates either tolerance or that initiates a distinct immune response⁸ depending on the type of substance, dosage, exposure duration and possibly the entry route to the liver. Thus, we hypothesized that a dietary pre-exposure to DON would modify the pre- or post-hepatic LPS-induced APR differently, with consequences for the ALB synthesis.

Significantly decreased FSR of ALB compared with the physiological saline treated control group was noticed under the conditions of an APR induced via a post-hepatic LPS challenge.²² A parallel chronic oral or acute i.v. DON exposure did not modify the LPS-induced drop in ALB FSR. Thus, the LPS-triggered APR dominated the ALB synthesis depressing effect irrespective of a simultaneous DON exposure.²² However, LPS might be increasingly transferred through an intestinal barrier compromised by DON as frequently discussed,^44–46 targeting the liver in the first pass. The human liver harbours approximately 80% of all body macrophages and is patrolled additionally by blood monocytes, the two cell populations mainly contributing to LPS clearance and induction of APR and SI.⁴⁷ Consequently, we assumed that an LPS entry via the portal route would have consequences on the outcome of APR, including ALB synthesis, other than a peripheral (jugular) LPS entry. There were indeed some hints that the magnitude of SI was more pronounced in DON-fed pigs challenged with LPS via the jugular route compared with the hepatic portal route²⁹ although the SI pacemaker cytokine TNF-α kinetics did not reflect similarly directed effects but rather responded uniformly to LPS irrespective of LPS infusion site or DON exposure.³⁰ The extent of the SI-associated lactic acidosis was significantly more pronounced following jugular LPS administration, and was discussed as consequence of a less pronounced post-hepatic LPS clearance capacity.²⁹ A chronic metabolic acidosis induced by an ammonium chloride exposure in healthy male humans induced a decreased ALB FSR, an increased urinary nitrogen excretion and a negative nitrogen balance.⁴⁸ Acute metabolic acidosis in healthy human subjects revealed an unchanged ALB FSR, but a decreased muscle FSR, which explained the negative nitrogen balance observed under both chronic and acute metabolic acidotic conditions.⁴⁹ Taken together, both chronic and acute metabolic acidosis might affect muscle protein turnover and hepatic ALB synthesis independently of other SI-associated pathophysiological alterations. However, under the conditions of the present experiment, the more pronounced lactic acidosis in pigs exposed to LPS via the jugular route²⁹ did not exacerbate the SI-related decrease in ALB synthesis when compared with the portal application route.

Toxic effects of alcohol include distorted mitochondria and alteration of the organizational arrangement of the endoplasmic reticulum, ultimately resulting in a disruption of the protein and consequently ALB synthesis machinery.⁵⁰ Therefore, acute hepatocyte lesions induced either directly by toxins or secondarily by an exuberant innate immune response might reduce the hepatocellular integrity and thus capacity for ALB synthesis. Although functional capacity for respiration and Ca²⁺ accumulation of isolated liver mitochondria was not impaired by any of the treatments, the histopathological examination revealed significant lesions including haemorrhage and inflammation primarily.⁴² Under the conditions of the present experiment the infiltration of the porcine liver by neutrophilic and eosinophilic granulocytes was observed across liver lobules,⁴² suggesting a uniform spreading of inflammation and inflammatory mediators. A SI in rats induced by s.c. turpentine injection caused a patchy pattern of immuno-stained ALB in perfused rat livers which reflected the hepatic architecture of the acinus with positively stained hepatocytes around the central veins. This result was interpreted as an ALB synthesis breakdown in a zonal pattern.⁵¹ An s.c. injection of rats with IL-1β was shown to induce SI and a depression of FSR of ALB.⁵² However, the absence of immuno-stained ALB in periportal fields was discussed as a consequence of a zonal IL-1β gradient rather than resulting from the oxygen and nutrient gradient down to the central veins.⁵¹ Based on the here established strong association between the histopathological cumulative score, largely determined by the uniform hepatic granulocyte infiltration, and the FSR of total liver proteins, it seems reasonable to conclude that functional impairment of the liver to synthesize ALB was associated to local inflammatory events.

ALB secretion time indicates the time required for synthesis and export of ALB by hepatocytes and does consequently provide further information on these processes as influenced by SI. The shortening in ALB secretion time observed with decreasing ALB FSR caused by SI might be interpreted as a consequence of an acute loss of hepatocellular integrity releasing labelled ALB molecules in the circulation, which could also contribute to an early depletion of hepatocytes from ALB. Further support for a compromised integrity of hepatocyte membranes comes from the increased peripheral activities of aspartate aminotransferase, γ-glutamyl-transferase and alkaline phosphatase.⁴² Moreover, genes involved in protein export were down-regulated under the conditions of the SI,⁵³ further supporting the idea of a passive loss of hepatocellular proteins across damaged cell membranes.

ALB synthesis is regarded as highly sensitive to altered Aa levels in general and to Trp availability in the free-protein synthesis precursor pool in particular.⁵⁴ Moreover, Trp was discussed with regard to restoring ALB synthesis in alcohol induced depression of ALB synthesis.⁵⁴,⁵⁵ Therefore, we assumed that the drop in ALB synthesis as determined in the present experiment upon LPS infusion could be due to an insufficient availability of free Trp and Aa usable for ALB synthesis. However, based on the Trp levels analysed in the hepatic free Aa precursor pool, we did not find indications of an LPS-induced limitation for this Aa. These results seem to contradict the increased mRNA expression of indolamine 2,3-dioxygenase (IDO) in LPS-treated pigs.⁵³ This ubiquitous enzyme catalyses the degradation of Trp to kynurenine and is mainly induced by pro-inflammatory stimuli.⁵⁶,⁵⁷ In contrast, the liver-specific Trp 2,3-dioxygenase (TDO), which catalyses the same reaction,⁵⁸ was down-regulated possibly as an attempt to save Trp for the synthesis of APP.⁵³

In addition to the not well-understood specific Trp influence, other Aa effects arising from the Aa composition of ALB have be taken in consideration. In contrast to other APP such as CRP, Fib and HP, the ALB molecule contains much higher proportions of Cys.¹⁵,⁵⁹,⁶⁰ Considering that ALB is a weak negative APP but accounts most for the total amount of all hepatic export proteins, a shortage in Cys availability might limit ALB synthesis. Out of the Aa analysed in the hepatic free Aa precursor pool, only Cys and the Lys degradation metabolite alpha-aminoadipic acid were significantly reduced upon LPS infusion, whereby the effects were more pronounced in the case of Cys. While a reduced α-aminoadipic acid content could be interpreted as a decreased Lys degradation to save this Aa for protein synthesis purposes, the LPS-induced reduction in Cys could indicate a certain limitation particularly for ALB synthesis. This conclusion is supported by the positive linear relationship between the Cys concentration in the free Aa precursor pool and the FSR of ALB and total hepatic proteins suggesting the FSR to be linearly dependent on the availability of free Cys. Interestingly, this linear relationship appeared to be even stronger for FSR of total proteins compared with ALB, which suggests that other hepatic proteins also rely on an adequate Cys availability, such as glutathione (GSH). One of the Aa of this tripeptide is Cys. GSH plays an important role in the enzymatic anti-oxidative defence system⁶¹ and is rapidly up-regulated in various tissues of LPS-challenged mice.⁶² Further information on the availability of protein synthesis precursor pool, i.e. free Aa, both for ALB and total hepatic protein synthesis can be gathered from the differences between the minimum and maximum FSR of total liver proteins. This difference was approximately 50% lower (6% vs. 3%) in LPS-challenged animals independently of LPS infusion site and feeding regimen, which might suggest that either more plasma-originating, or fewer hepatocellular free Aa were used or available for protein synthesis in order to meet the actual needs. This conclusion is also consistent with the idea of a partial mixing of both precursor pools due to hepatocellular lesions.

The reasons for the reduced availability of Cys might not only be based on a higher actual requirement but might also be caused by a reduced perfusion of hepatic sinusoids, ultimately resulting in a decreased nutrient delivery to the hepatocytes. SI is associated with a redistribution of intrahepatic blood flow due to the interactions between Kupffer cells, infiltrating leukocytes and sinusoidal endothelial cells resulting in a decreased perfusion and blood flow velocity in the liver sinusoids.⁶³ Together with the disseminated intravascular coagulation and the associated formation of micro-thrombi, the ischemia and organ damage are exacerbated.⁶⁴

In contrast to the Aa pattern of the precursor pool, the Aa composition of the protein hydrolysate did not provide hints at specific associations to ALB. However, in spite of the LPS-induced trend to increase the concentrations of His, Asp, Ala, Val and Leu, these effects appeared to reflect systematic LPS-induced alterations in hepatic proteins comprising both constitutive, in statu nascendi export proteins and other inflammation-related proteins.

Further support for the particular role of sulphur-containing Aa including Met and Cys for FSR of ALB comes from an experiment where an insufficient dietary supply with these Aa significantly reduced ALB FSR in LPS-challenged pigs.⁶⁵ In contrast, ALB FSR was not compromised in pigs challenged with LPS but adequately supplied with Met and Cys when compared with the non-challenged control group.⁶⁵

APR-Induced alterations in expression of ALB mRNA might also contribute to the observed marked decrease in FSR of ALB. However, we failed to detect any decrease in ALB mRNA expression due to any of the treatments 195 min after the initiation of the infusions. Others have examined the kinetic relationships between ALB mRNA expression and ALB synthesis in more detail. The ratio between murine hepatic ALB synthesis rate and mRNA levels remained relatively stable over time after turpentine induced APR. Based on these results it was concluded that APP and ALB synthesis adjustment during APR is not regulated by the rapidity of translation of individual mRNA molecules but by the absolute mRNA level. This, in turn, might be controlled by mRNA synthesis and/or degradation.⁶⁶ ALB mRNA levels were down-regulated to reach a nadir 36 h after turpentine injection. The decrease started at the first liver sampling point at 6 h p.i. Positive APP such as transferrin, fibrinogen and α1-acid glycoprotein peaked markedly in their mRNA abundance after 36 h, 24 h and 36 h, respectively, and were characterized by different half-lives. Similar findings were reported in turpentine-injected and E. coli-infected rats.⁶⁷,⁶⁸

We assessed the ALB mRNA expression solely 195 min after the beginning of the LPS challenge. Therefore, this time span might have been too short to induce an effect on ALB mRNA expression. Consequently, the observed marked early drop in ALB FSR might have been caused by other mechanisms as discussed above.

In contrast to ALB mRNA, mRNA levels of all other APP were significantly up-regulated ∼3 h after starting LPS infusions, although the corresponding APP did not increase in systemic circulation within this period but rather showed significant decreases in some cases. This finding was somewhat unexpected, as most of them would be expected to be more or less induced in pigs as a result of an APR caused by several sterile and infectious stimuli.^69–74 In discussing these time-dependent increases of APP with the decreases/no changes observed in the present experiment it needs to be considered that the first blood sample was taken 24 h after the initiation of the APR in most of the published porcine studies, whereas we specifically examined the first 3 h of the APR. Similarly to our study, Frank et al.⁷⁵ also failed to detect increases of CRP, HP or ceruloplasmin (Cp) after i.m. injection of 25 or 50 µg LPS/kg BM. Only for SAA was a significant increase noticed. However, APPs were measured only 48 h after the LPS challenge, which could also mean that kinetics of CRP, HP and Cp were different from that of SAA and that peak responses were possibly not recognized.

Only a few experiments were identified which reported APP concentrations for time spans markedly lower than 24 h after the challenge. An experimental infection of pigs with E. coli K88 resulted in an increase in HP concentration as early as 6 h p.i.⁷⁶ An i.p. LPS challenge of 5 µg/kg BM failed to trigger a HP response after 2, 4, 8, 12 and 24 h, while CRP peaked sharply after 12 h and SAA fluctuated significantly but independently of time p.i.⁷⁴ Therefore, the first hours of an APR appear to be differently regulated when compared with a long-term observation.

The unchanged or even decreased levels of the analysed positive APP reported herein irrespective of an up-regulated mRNA expression might be the result of a time lag required for translation. However, based on the present and other results²⁰,²² suggesting that only approximately 20 min are required to synthesize and export both ALB and Fib, and that this time span might also apply for other hepatic export proteins, the translation step does not appear to be the reason for the decreased or unaltered levels of APP. Therefore, an assumed initial increase in synthesis of these APPs might have been insufficient to compensate the level of their consumption; in terms of protein turnover, the level of degradation/elimination and/or extravasation might have been higher than the level of their de novo synthesis. If true, then the observed more pronounced reductions in the plasma concentrations of MAP and SAA in septicaemic groups pre-exposed to DON might suggest interactive effects between DON and LPS exposure leading to a distinctive depression in synthesis of these proteins and/or imbalance between synthesis and usage. Taking additionally into account that mRNA expression of MAP and SAA were similarly up-regulated compared with the LPS-challenged CON groups, the transcriptional level of regulation was putatively not responsible for the observed interactive effects. The situation has to be differently discussed for ALB concentration change and final ALB concentration. It appeared that the ALB concentrations were more reduced in septicaemic groups pre-exposed with DON, although ALB mRNA expression remained unaltered and FSR of ALB was similarly decreased in all LPS-challenged groups irrespective of feeding and infusion group. Thus, ALB concentration levels under the conditions of an SI appeared to be influenced by further mechanisms beside the major impact of ALB synthesis depression.

We also tested the hypothesis that a dietary pre-exposure to DON would increase the transfer of intestinal-originating LPS through a DON-associated destruction of the mucosal barrier, as discussed above, whereby hepatic responsiveness to LPS and DON with consequences for hepatic ALB synthesis could be altered. However, no depressing effects on ALB and total liver protein FSR were found in the present experiment when looking at the consequences of DON exposure alone without an artificial LPS challenge. These results are in contrast to earlier findings where chronic oral DON exposure significantly depressed²⁰ or even stimulated ALB FSR.²² While a depression of ALB FSR is to be expected based on the mode of action of DON, a stimulation of FSR is more difficult to discuss.²² Although the latter two, and this experiment applied a restricted feeding regimen over 4–5 wk to avoid dietary effects following a DON-induced anorexia and used male castrated pigs comparable in age, diets contained different DON levels. While general effects of the particular experiments cannot be excluded, a DON dose-related effect on ALB FSR might be deduced. Thus, a depression, no-effect and stimulation of ALB FSR were associated with dietary DON concentrations of 5.7 mg/kg feed, 4.6 mg/kg and 3.1 mg/kg, respectively.

Besides the observation that DON alone failed to influence hepatic ALB and total protein synthesis, additional modifying effects of LPS transferred through a DON-compromised mucosal barrier can be excluded as pigs fed the DON-contaminated diet showed LPS levels both in hepatic portal and jugular vein comparable to those measured in the CON-fed group.⁷⁷ This finding is in line with earlier results demonstrating that a chronic DON exposure fails to influence mucosal tight junction proteins.⁷⁸,⁷⁹

Conclusions

The marked depression of ALB FSR observed 195 min after initiating of an APR through a pre- or post-hepatic LPS challenge was not associated to a down-regulated ALB mRNA expression but by a reduced cysteine availability in the protein synthesis precursor pool. Dietary chronic pre-exposure with DON neither depressed ALB and total hepatic protein FSR in unchallenged pigs, nor gave rise to any interactive effects, with the LPS-induced APR suggesting that observed adverse effects on liver protein synthesis were dominated by the consequences of the SI.

In contrast, the mRNA expression of the positive APPs Fib, HP, MAP, CRP, LBP and SAA was significantly up-regulated due to LPS stimulation independently of feeding group and infusion site. This up-regulation was not accompanied by increases in plasma levels of the corresponding APPs, which could hint at an imbalance between synthesis and consumption.

Kinetic studies with frequent blood and liver sample collections covering a time span of several days are required to fully understand the regulation of APP in the course of a systemic inflammatory response in the pig.

Supplemental Material

sj-pdf-1-ini-10.1177_1753425920937778 - Supplemental material for Oral exposure of pigs to the mycotoxin deoxynivalenol does not modulate the hepatic albumin synthesis during a LPS-induced acute-phase reaction

Supplemental material, sj-pdf-1-ini-10.1177_1753425920937778 for Oral exposure of pigs to the mycotoxin deoxynivalenol does not modulate the hepatic albumin synthesis during a LPS-induced acute-phase reaction by Sven Dänicke, Erik Bannert, Tanja Tesch, Susanne Kersten, Jana Frahm, Susanne Bühler, Helga Sauerwein, Solvig Görs, Stefan Kahlert, Hermann-Josef Rothkötter, Cornelia C Metges and Jeannette Kluess in Innate Immunity

Footnotes

Acknowledgements

The authors would like to thank Nicola Mickenautsch for performing the isotope analyses.

Declaration of conflicting interests

The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported financially by Deutsche Forschungsgemeinschaft (DFG DA 558/1-4 and RO 743/3-3).

ORCID iDs

Sven Dänicke

Stefan Kahlert

Supplemental material

Supplemental material for this article is available online.

References

Raetz

Whitfield

Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71: 635–700.

Schletter

Heine

Ulmer

, et al. Molecular mechanisms of endotoxin activity. Arch Microbiol 1995; 164: 383–389.

Morrison

Ulevitch

RJ.

The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 1978; 93: 526–618.

Alexander

Rietschel

ET.

Bacterial lipopolysaccharides and innate immunity. J End Res 2001; 7: 167–202.

Fitzgerald

Rowe

Golenbock

DT.

Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect 2004; 6: 1361–1367.

Freudenberg

Tchaptchet

Keck

, et al. Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: Benefits and hazards of LPS hypersensitivity. Immunobiology 2008; 213: 193–203.

Chou

Chuang

Eng

, et al. Effects of hepatocyte CD14 Up-regulation during cholestasis on endotoxin sensitivity. PLoS ONE 2012; 7.

Strnad

Tacke

Koch

, et al. Liver – guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 2017; 14: 55–66.

Heumann

Roger

Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323: 59–72.

10.

Baumann

Gauldie

The acute-phase response. Immunol Tod 1994; 15: 74–80.

11.

Cray

Zaias

Altman

NH.

Acute phase response in animals: A review. Comp Med 2009; 59: 517–526.

12.

Beisel

WR.

Metabolic response of host to infections. In: Textbook of Pediatric Infectious Diseases. Elsevier-Saunders, Philadelphia, PA, 1998, pp. 54–69.

13.

Petersen

Nielsen

Heegaard

PM.

Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 2004; 35: 163–187.

14.

Murata

Shimada

Yoshioka

Current research on acute phase proteins in veterinary diagnosis: An overview. Vet J 2004; 168: 28–40.

15.

Reeds

Fjeld

Jahoor

Do the differences between the amino acid compositions of acute-phase and muscle proteins, have a bearing on nitrogen loss in traumatic states?

J Nutr 1994; 124: 906–910.

16.

European Food Safety Authority. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to deoxynivalenol (DON) as undesirable substance in animal feed. EFSA J 2004; 73: 1–42 (available at: http://www.efsa.eu.int/).

17.

European Food Safety Authority. Scientific Report of EFSA - Deoxynivalenol in food and feed: occurrence and exposure. EFSA J 2013; 11: 3379.

18.

European Food Safety Authority. Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed. EFSA J 2017; 15: e04718.

19.

European Commission. Commission recommendation of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin A, T-2 and HT-2 and fumonisins in products intended for animal feeding. Official J Eur Union 2006; 229: 7–9.

20.

Goyarts

Grove

Dänicke

Effects of the Fusarium toxin deoxynivalenol from naturally contaminated wheat given subchronically or as one single dose on the in vivo protein synthesis of peripheral blood lymphocytes and plasma proteins in the pig. Food Chem Toxicol 2006; 44: 1953–1965.

21.

Dänicke

Goyarts

Döll

, et al. Effects of the Fusarium toxin deoxynivalenol on tissue protein synthesis in pigs. Toxicol Lett 2006; 165: 297–311.

22.

Kullik

Brosig

Kersten

, et al. Interactions between the Fusarium toxin deoxynivalenol and lipopolysaccharides on the in vivo protein synthesis of acute phase proteins, cytokines and metabolic activity of peripheral blood mononuclear cells in pigs. Food Chem Toxicol 2013; 57: 11–20.

23.

Kullik

Brosig

Kersten

, et al. Interactions of deoxynivalenol and lipopolysaccharides on tissue protein synthesis in pigs. World Mycotoxin J 2013; 6: 185–197.

24.

Ganey

Roth

RA.

Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology 2001; 169: 195–208.

25.

Islam

Pestka

JJ.

LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse. Toxicol Appl Pharmacol 2006; 211: 53–63.

26.

Zhou

Harkema

Hotchkiss

, et al. Lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol) synergistically induce apoptosis in murine lymphoid organs. Toxicol Sci 2000; 53: 253–263.

27.

Levitt

MD.

Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016; 9: 229–255.

28.

Rothschild

Oratz

Schreiber

SS.

Albumin metabolism. Gastroenterology 1973; 64: 324–337.

29.

Bannert

Tesch

Kluess

, et al. Metabolic and hematological consequences of dietary deoxynivalenol interacting with systemic Escherichia coli lipopolysaccharide. Toxins (Basel) 2015; 7: 4773–4796.

30.

Tesch

Bannert

Kluess

, et al. Does dietary deoxynivalenol modulate the acute phase reaction in endotoxaemic pigs?-Lessons from clinical signs, white blood cell counts, and TNF-alpha. Toxins 2016; 8.

31.

Ballmer

McNurlan

Essen

, et al. Albumin synthesis rates measured with [²H₅ring]phenylalanin are not responsive to short-term intravenous nutrients in healthy humans. J Nutr 1995; 125: 512–519.

32.

McNurlan

Tomkins

Garlick

PJ.

The effect of starvation on the rate of protein synthesis in rat liver and small intestine. Biochem J 1979; 178: 373–379.

33.

Dänicke

Swiech

Goyarts

, et al. Measurement of albumin synthesis in the pig by using L-[²H₅]phenylalanine as a stable isotope tracer. Landbauforsch Völk 2005; 55: 245–253.

34.

Hiss

Knura-Deszcka

Regula

, et al. Development of an enzyme immuno assay for the determination of porcine haptoglobin in various body fluids: testing the significance of meat juice measurements for quality monitoring programs. Vet Immunol Immunopathol 2003; 96: 73–82.

35.

Aranda

LaJoie

Jorcyk

CL.

Bleach gel: A simple agarose gel for analyzing RNA quality. Electrophoresis 2012; 33: 366–379.

36.

Coulouris

Zaretskaya

, et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform 2012; 13.

37.

Vandesompele

De Preter

Pattyn

, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3.

38.

Hellemans

Mortier

De Paepe

, et al. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8.

39.

Ballmer

McNurlan

Milne

, et al. Measurement of albumin synthesis in humans: A new approach employing stable isotopes. Am J Physiol 1990; 259: E797–E803.

40.

Yang

Lin

JH.

Variation of heart size and its correlation with growth performance and vascular space in domestic pigs. Anim Sci 1997; 64: 523–528.

41.

TIBCO Software Inc. Statistica (data analysis software system), version 13. http://statistica.io. 2017.

42.

Renner

Kahlert

Tesch

, et al. Chronic DON exposure and acute LPS challenge: effects on porcine liver morphology and function. Mycotoxin Res 2017; 33: 207–218.

43.

Knolle

Gerken

Local control of the immune response in the liver. Immunol Rev 2000; 174: 21–34.

44.

Pinton

Braicu

Nougayrede

, et al. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism. J Nutr 2010; 140: 1956–1962.

45.

Bracarense

Lucioli

Grenier

, et al. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br J Nutr 2012; 107: 1776–1786.

46.

Pinton

Nougayrede

Del Rio

, et al. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol 2009; 237: 41–48.

47.

Heymann

Tacke

Immunology in the liver-from homeostasis to disease. Nat Rev Gastroenterol Hepatol 2016; 13: 88–110.

48.

Ballmer

McNurlan

Hunter

, et al. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995; 95: 39–45.

49.

Kleger

Turgay

Imoberdorf

, et al. Acute metabolic acidosis decreases muscle protein synthesis but not albumin synthesis in humans. Am J Kidney Dis 2001; 38: 1199–1207.

50.

Rothschild

Oratz

Schreiber

SS.

Alcohol, amino acids, and albumin synthesis. Gastroenterology 1974; 67: 1200–1213.

51.

Ballmer

Ballmerhofer

Repond

, et al. Acute suppression of albumin synthesis in systemic inflammatory disease - an individually graded response of rat hepatocytes. J Histochem Cytochem 1992; 40: 201–206.

52.

Ballmer

McNurlan

Grant

, et al. Down-regulation of albumin synthesis in the rat by human recombinant interleukin-1 beta or turpentine and the response to nutrients. JPEN-Parenter Enter 1995; 19: 266–271.

53.

Heymann

Billenkamp

Oster

, et al. Transcriptomic analysis of the inflamed porcine liver: Effects of a dietary pre-exposure with the Fusarium mycotoxin deoxynivalenol (DON) In preparation. 2020.

54.

Rothschild

Oratz

Schreiber

SS.

Albumin metabolism. Prog Liver Dis 1972; 4: 19–29.

55.

Rothschild

Oratz

Mongelli

, et al. Alcohol-induced depression of albumin synthesis: Reversal by tryptophan. J Clin Invest 1971; 50: 1812–1818.

56.

Wirthgen

Kanitz

Tuchscherer

, et al. IDO activation by LPS stimulation: Physiological consequences and their blocking by 1-Methyl-Tryptophan (1-MT) in a pig model. Neuroimmunomodulation 2011; 18: 409–410.

57.

Wirthgen

Tuchscherer

Otten

, et al. Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model. Innate Immunity 2014; 20: 30–39.

58.

Floc’h Nl Otten

Merlot

le Floc’h

Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 2011; 41: 1195–1205.

59.

Carlsson

RNK

Ingvarsson

Karlsson

BM.

Isolation and characterization of albumin from porcine serum, colostrum and urine. Int J Biochem 1977; 8: 285–294.

60.

Peters

The albumin molecule: Its structure and chemical properties. In: Peters

(ed) All About Albumin. San Diego: Academic Press, 1995, pp. 9–II.

61.

Ghezzi

Role of glutathione in immunity and inflammation in the lung. Int J Gen Med 2011; 4: 105–113.

62.

Seemann

Zohles

Lupp

Comprehensive comparison of three different animal models for systemic inflammation. J Biomed Sci 2017; 24.

63.

Spapen

Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken) 2008; 291: 714–720.

64.

Hopper

Bateman

An updated view of hemostasis: Mechanisms of hemostatic dysfunction associated with sepsis. J Vet Emerg Crit Car 2005; 15: 83–91.

65.

Litvak

Htoo

de Lange

CFM.

Restricting sulfur amino acid intake in growing pigs challenged with lipopolysaccharides decreases plasma protein and albumin synthesis. Can J Anim Sci 2013; 93: 505–515.

66.

Schreiber

Aldred

Thomas

, et al. Levels of messenger ribonucleic-acids for plasma-proteins in rat-liver during acute experimental inflammation. Inflammation 1986; 10: 59–66.

67.

Ruot

Breuille

Rambourdin

, et al. Synthesis rate of plasma albumin is a good indicator of liver albumin synthesis in sepsis. Am J Physiol-Endoc M 2000; 279: E244–E251.

68.

Geiger

Andus

Klapproth

, et al. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717–721.

69.

Sorensen

Tegtmeier

Andresen

, et al. The porcine acute phase protein response to acute clinical and subclinical experimental infection with Streptococcus suis. Vet Immunol Immunopathol 2006; 113: 157–168.

70.

Pomorska-Mol

Urbaniak

Markowska-Daniel

Porcine acute phase protein response to experimental infection with Bordetella bronchiseptica. Bull Vet Inst Pulawy 2011; 55: 371–375.

71.

Lampreave

Gonzalezramon

Martinezayensa

, et al. Characterization of the acute-phase serum-protein response in pigs. Electrophoresis 1994; 15: 672–676.

72.

Pomorska-Mol

Markowska-Daniel

Kwit

, et al. Kinetics of the response of four positive acute phase proteins in pigs experimentally infected with toxigenic Pasteurella multocida. Vet Microbiol 2011; 152: 429–435.

73.

Carpintero

Alonso

Pineiro

, et al. Pig major acute-phase protein and apolipoprotein A-I responses correlate with the clinical course of experimentally induced African swine fever and Aujeszky’s disease. Vet Res 2007; 38: 741–753.

74.

Llamas Moya

Boyle

Lynch

, et al. Pro-inflammatory cytokine and acute phase protein responses to low-dose lipopolysaccharide (LPS) challenge in pigs. Anim Sci 2007; 82: 527–534.

75.

Frank

Mellencamp

Carroll

, et al. Acute feed intake and acute-phase protein responses following a lipopolysaccharide challenge in pigs from two dam lines. Vet Immunol Immunopathol 2005; 107: 179–187.

76.

Kiarie

Slominski

Krause

, et al. Acute phase response of piglets fed diets containing non-starch polysaccharide hydrolysis products and egg yolk Abs following an oral challenge with Escherichia coli (K88). Can J Anim Sci 2009; 89: 353–360.

77.

Kahlert

Renner

Kluess

, et al. Effects of deoxynivalenol-feed contamination on circulating LPS in pigs. Innate Immun 2019: 1753425919829552.

78.

Klunker

Kahlert

Panther

, et al. Deoxynivalenol and E.coli lipopolysaccharide alter epithelial proliferation and spatial distribution of apical junction proteins along the small intestinal axis. J Anim Sci 2012; 90: 276–285.

79.

Dänicke

Brosig

Klunker

, et al. Systemic and local effects of the Fusarium toxin deoxynivalenol (DON) are not alleviated by dietary supplementation of humic substances (HS). Food Chem Toxicol 2012; 50: 979–988.

80.

Nygard

Jorgensen

Cirera

, et al. Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol 2007; 8: 67.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB